Concepedia

Amy Rommel

AR

Statistics

Publications

5

Citations

586

H-Index

5

Active since

2013

Affiliations

Salk Institute for Biological Studies(Current)

The University of Texas Southwestern Medical Center

The University of Texas MD Anderson Cancer Center

Case Western Reserve University

Amy Rommel is an author at Salk Institute for Biological Studies specializing in medicine, cell biology, and transcriptional regulation.

Top concepts

Publications per year

2013–2018

5

Publications

5

Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence

Gabriele Sulli, Amy Rommel, Xiaojie Wang et al. · Nature · 2018 · 393 citations · Full text

, , +8

Catalase Abrogates β-Lapachone–Induced PARP1 Hyperactivation–Directed Programmed Necrosis in NQO1-Positive Breast Cancers

Erik A. Bey, Kathryn E. Reinicke, Melissa C. Srougi et al. · Molecular Cancer Therapeutics · 2013 · 98 citations · Full text

Kub5-Hera, the human Rtt103 homolog, plays dual functional roles in transcription termination and DNA repair

Julio C. Morales, P. Richard, Amy Rommel et al. · Nucleic Acids Research · 2014 · 52 citations · Full text

, , +19

Dovitinib enhances temozolomide efficacy in glioblastoma cells

Thatchawan Thanasupawat, Suchitra Natarajan, Amy Rommel et al. · Molecular Oncology · 2017 · 28 citations · Full text

Kub5-Hera <i>RPRD1B</i> Deficiency Promotes “BRCAness” and Vulnerability to PARP Inhibition in BRCA-proficient Breast Cancers

Edward A. Motea, Farjana Fattah, Ling Xiao et al. · Clinical Cancer Research · 2018 · 15 citations · Full text

1–5 of 5